loadpatents
name:-0.024242877960205
name:-0.011241912841797
name:-0.00042104721069336
EXLEY; Mark A. Patent Filings

EXLEY; Mark A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for EXLEY; Mark A..The latest application filed is for "methods and compositions for treatment of metabolic disorders".

Company Profile
0.9.26
  • EXLEY; Mark A. - Chestnut Hill MA
  • Exley; Mark A. - Brookline MA US
  • Exley; Mark A. - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Treatment Of Metabolic Disorders
App 20180296671 - EXLEY; Mark A. ;   et al.
2018-10-18
Methods and compositions for treatment of metabolic disorders
Grant 9,907,848 - Exley , et al. March 6, 2
2018-03-06
Compositions And Methods Of Monoclonal And Polyclonal Antibodies Specific For T Cell Subpopulations
App 20150299320 - Exley; Mark A. ;   et al.
2015-10-22
Methods And Compositions For Treatment Of Metabolic Disorders
App 20140079771 - EXLEY; Mark A. ;   et al.
2014-03-20
Allergenic proteins and peptides from Japanese cedar pollen
Grant 8,540,999 - Griffith , et al. September 24, 2
2013-09-24
Compositions And Methods Of Monoclonal And Polyclonal Antibodies Specific For T Cell Subpopulations
App 20120258040 - Exley; Mark A. ;   et al.
2012-10-11
Use Of Anti-cd1 Antibodies For The Modulation Of Immune Responses
App 20120164138 - Exley; Mark A. ;   et al.
2012-06-28
Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
Grant 8,138,314 - Exley , et al. March 20, 2
2012-03-20
Use of anti-CD1 antibodies for the modulation of immune responses
Grant 8,084,020 - Exley , et al. December 27, 2
2011-12-27
Hapten-carrier Conjugates For Use In Drug-abuse Therapy And Methods For Preparation Of Same
App 20100209449 - Swain; Philip A. ;   et al.
2010-08-19
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20100105672 - Swain; Philip A. ;   et al.
2010-04-29
Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same
App 20100068222 - Swain; Philip A. ;   et al.
2010-03-18
Immunotherapy For Hematological Malignancies
App 20090068210 - Munshi; Nikhil C. ;   et al.
2009-03-12
Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
App 20070160600 - Exley; Mark A. ;   et al.
2007-07-12
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286095 - Swain; Philip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286097 - Swain; Philiip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286099 - Swain; Philip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286098 - Swain; Philip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286094 - Swain; Philip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060286096 - Swain; Philip A. ;   et al.
2006-12-21
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060280735 - Swain; Philip A. ;   et al.
2006-12-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060280736 - Swain; Philip A. ;   et al.
2006-12-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060239997 - Swain; Philip A. ;   et al.
2006-10-26
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20060058220 - Swain; Philip A. ;   et al.
2006-03-16
Use of anti-cd1 antibodies for the modulation of immune responses
App 20060002927 - Exley; Mark A. ;   et al.
2006-01-05
Allergenic proteins and peptides from Japanese cedar pollen
Grant 6,982,326 - Griffith , et al. January 3, 2
2006-01-03
Allergenic proteins and peptides from Japanese cedar pollen
App 20050152927 - Griffith, Irwin J. ;   et al.
2005-07-14
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20050124061 - Swain, Philip A. ;   et al.
2005-06-09
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20030069400 - Swain, Philip A. ;   et al.
2003-04-10
Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
App 20020164331 - Exley, Mark A. ;   et al.
2002-11-07
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
App 20020032316 - Swain, Philip A. ;   et al.
2002-03-14
T cell peptides of the CRX JII allergen
Grant 6,090,386 - Griffith , et al. July 18, 2
2000-07-18
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
Grant 5,876,727 - Swain , et al. March 2, 1
1999-03-02
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
Grant 5,760,184 - Swain , et al. June 2, 1
1998-06-02
Company Registrations
NCAGE Code46CE6EXLEY MARK A
NCAGE Code4WWX0EXLEY, MARK A!DBA USE CAGE CODE 46CE6 FOR!CATALOGING
CAGE Code46CE6EXLEY, MARK A
CAGE Code4WWX0EXLEY, MARK A USE CAGE CODE 46CE6 FOR CATALOGING

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed